Adaptive Biotechnologies Corporation (ADPT) vs Erasca, Inc. (ERAS)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Erasca, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$29.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ERAS
Erasca, Inc.
$14.72HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADPT vs ERAS
growth of $100 · dividends reinvested · last 5yADPT -15.3% (-3.3%/yr)ERAS -15.5% (-3.3%/yr)ADPT compounded faster over this window
ADPT ERAS
ADPT vs ERAS: by the numbers
- •ERAS is the larger company ($5.11B vs $4.78B market cap).
- •Both run net losses; ERAS's is the smaller (0.00% vs -20.73% net margin).
Metrics side by side
Valuation
| Metric | ADPT | ERAS |
|---|---|---|
| P/S ratio | 15.50 | N/A |
| P/B ratio | 33.42 | 14.12 |
Profitability
| Metric | ADPT | ERAS |
|---|---|---|
| Gross margin | 75.44% | 0.00% |
| Operating margin | -20.62% | 0.00% |
| Net margin | -20.73% | 0.00% |
| ROE | -44.68% | -79.37% |
| ROIC | -6.67% | -38.03% |
Growth (annualized)
| Metric | ADPT | ERAS |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | N/A |
| Total return CAGR (5Y) | -1.77% | -8.34% |
Frequently asked
- How have ADPT and ERAS total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and ERAS delivered -8.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEErasca ROEAdaptive Biotechnologies operating marginErasca operating marginAdaptive Biotechnologies revenue growthErasca revenue growthAdaptive Biotechnologies free cash flowErasca free cash flow
Adaptive Biotechnologies & Erasca appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.